Uteron Pharma sprl is a Research & Development oriented company and a subsidiary of Allergan plc. Allergan plc is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing brand, branded generic, Over-the Counter (OTC) and biosimilar products.
Odyssea Pharma sprl is designated as one of Allergan Centre of Excellence for women’s health delivering product development, GMP manufacturing of Levosert™ hormonal intra-uterine device and quality & regulatory expertise from a custom-designed facility located in Liège, Belgium.
The company has successfully developed Levosert™ (levonorgestrel-releasing Intra-Uterine Device), and is currently launching it on the world market
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.